Skip to content

Clinical trials

Phase 2 Stomach Neoplasms trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 2 Country / region: Switzerland Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20081
20101
20151
20181
20191
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting2
Active, not recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Bayer1
European Organisation for Research and Treatment of Cancer - EORTC1
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1
Merck KGaA, Darmstadt, Germany1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1
Oncology Institute of Southern Switzerland1
Sanofi1
Swiss Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms11
Biliary Tract Neoplasms3
Colorectal Neoplasms3
Endometrial Neoplasms3
Esophageal Neoplasms3
Ovarian Neoplasms3
Pancreatic Neoplasms3
Adenocarcinoma2
Breast Neoplasms2
Urinary Bladder Neoplasms2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.